Near-Infrared Spectroscopy derived Cerebral Autoregulation Indices Independently Predict Clinical Outcome in Acutely Ill Comatose Patients
| Autor: | Lucia Rivera-Lara, Andres Zorrilla-Vaca, Dhaval Sha, Romegryko Geocadin, Batya R. Radzik, Caitlin Palmisano, Wendy C. Ziai, Ryan Healy, Luciano Ponce-Mejia, Charles H. Brown, Charles W. Hogue, Mirinda Anderson White |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Male
medicine.medical_specialty Cerebral autoregulation Article Cohort Studies 03 medical and health sciences 0302 clinical medicine 030202 anesthesiology Interquartile range Internal medicine medicine Homeostasis Humans Hospital Mortality Prospective Studies Cerebral perfusion pressure Coma Prospective cohort study Spectroscopy Near-Infrared business.industry Mortality rate Odds ratio Middle Aged Survival Analysis Anesthesiology and Pain Medicine Cerebral blood flow Brain Injuries Cerebrovascular Circulation Cardiology Surgery Female Neurology (clinical) medicine.symptom business 030217 neurology & neurosurgery |
| Zdroj: | J Neurosurg Anesthesiol |
| Popis: | Objective Outcome prediction in comatose patients with acute brain injury remains challenging. Regional cerebral oxygenation (rSO2) derived from near-infrared spectroscopy (NIRS) is a surrogate for cerebral blood flow and can be used to calculate cerebral autoregulation (CA) continuously at the bedside from the derived cerebral oximetry index (COx). We hypothesized that COx derived thresholds for CA are associated with outcomes in patients with acute coma from neurological injury. Methods A prospective cohort study was conducted in 88 acutely comatose adults with heterogenous brain injury diagnoses who were continuously monitored with COx for up to 3 consecutive days. Multivariable logistic regression was performed to investigate association between averaged COx and short (in-hospital and 3 mo) and long-term (6 mo) outcomes. Results Six month mortality rate was 62%. Median COx in nonsurvivors at hospital discharge was 0.082 [interquartile range, IQR: 0.045 to 0.160] compared with 0.042 [IQR: -0.005 to 0.110] in survivors (P=0.012). At 6 months, median COx was 0.075 [IQR: 0.27 to 0.158] in nonsurvivors compared with 0.029 [IQR: -0.015 to 0.077] in survivors (P=0.02). In the multivariable logistic regression model adjusted for confounders, average COx ≥0.05 was associated with both in-hospital mortality (adjusted odds ratio [OR]=2.9, 95% confidence interval [CI]=1.15-7.33, P=0.02), mortality at 6 months (adjusted OR=4.4, 95% CI=1.41-13.7, P=0.01), and severe disability (modified Rankin Score ≥4) at 6 months (adjusted OR=4.4, 95% CI=1.07-17.8, P=0.04). Area under the receiver operating characteristic curve for predicting mortality and severe disability at 6 months were 0.783 and 0.825, respectively. Conclusions Averaged COx ≥0.05 is independently associated with short and long-term mortality and long-term severe disability in acutely comatose adults with neurological injury. We propose that COx ≥0.05 represents an accurate threshold to predict long-term functional outcome in acutely comatose adults. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|